We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+11.03%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$10.6B
AUM Growth
+$1.17B
Cap. Flow
+$3.01B
Cap. Flow %
28.27%
Top 10 Hldgs %
22.3%
Holding
850
New
52
Increased
273
Reduced
342
Closed
48

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$96.9M
2
MRK icon
Merck
MRK
+$73.5M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$57.1M
4
ILMN icon
Illumina
ILMN
+$40.4M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.2M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$57.2M
2
IMMU
Immunomedics Inc
IMMU
+$51.7M
3
KMB icon
Kimberly-Clark
KMB
+$28.5M
4
BPMC
Blueprint Medicines
BPMC
+$26.5M
5
ANET icon
Arista Networks
ANET
+$22.7M

Sector Composition

Rank Sector Weight
1 Healthcare 35.77%
2 Technology 20.35%
3 Consumer Discretionary 9.49%
4 Communication Services 7.69%
5 Financials 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OKE icon
376
Oneok
OKE
$56.1B
$4.03M 0.04%
155,294
+22,580
+17% +$629K
HSY icon
377
Hershey
HSY
$35.9B
$4.01M 0.04%
27,946
-40,898
-59% -$5.8M
GE icon
378
GE Aerospace
GE
$368B
$3.99M 0.04%
128,487
-3,170
-2% -$103K
BAX icon
379
Baxter International
BAX
$13.8B
$3.98M 0.04%
49,559
-1,755
-3% -$148K
EXC icon
380
Exelon
EXC
$46.6B
$3.98M 0.04%
155,856
-944
-0.6% -$25K
NBL
381
DELISTED
Noble Energy, Inc.
NBL
$3.94M 0.04%
+460,929
New +$4.5M
NUAN
382
DELISTED
Nuance Communications, Inc.
NUAN
$3.92M 0.04%
118,000
-39,000
-25% -$1.13M
IP icon
383
International Paper
IP
$22.8B
$3.86M 0.04%
100,664
+26,492
+36% +$935K
ALV icon
384
Autoliv
ALV
$9.09B
$3.78M 0.04%
51,860
+46,500
+868% +$3.3M
CME icon
385
CME Group
CME
$96.1B
$3.75M 0.04%
22,430
-1,640
-7% -$276K
CPRT icon
386
Copart
CPRT
$27.4B
$3.73M 0.04%
126,780
+14,584
+13% +$353K
RF icon
387
Regions Financial
RF
$26.3B
$3.71M 0.03%
321,420
+4,826
+2% +$53.8K
ZM icon
388
Zoom
ZM
$27.1B
$3.71M 0.03%
+7,883
New +$2.52M
DVA icon
389
DaVita
DVA
$15.3B
$3.69M 0.03%
43,101
+1,403
+3% +$120K
TMUS icon
390
T-Mobile US
TMUS
$186B
$3.69M 0.03%
32,228
+4,000
+14% +$443K
COP icon
391
ConocoPhillips
COP
$145B
$3.66M 0.03%
111,575
-3,935
-3% -$149K
GLW icon
392
Corning
GLW
$116B
$3.66M 0.03%
112,870
+52,182
+86% +$1.61M
NGM
393
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$3.64M 0.03%
228,764
– –
TNDM icon
394
Tandem Diabetes Care
TNDM
$1.3B
$3.63M 0.03%
32,000
-3,000
-9% -$315K
MCHP icon
395
Microchip Technology
MCHP
$40.7B
$3.62M 0.03%
70,374
-52,526
-43% -$2.73M
ESPR
396
DELISTED
Esperion Therapeutics
ESPR
$3.57M 0.03%
95,955
-20,849
-18% -$826K
AVTR icon
397
Avantor
AVTR
$9.37B
$3.55M 0.03%
157,963
-13,037
-8% -$271K
RDUS
398
DELISTED
Radius Health, Inc.
RDUS
$3.54M 0.03%
312,025
– –
MRVL icon
399
Marvell Technology
MRVL
$165B
$3.54M 0.03%
89,050
-2,876
-3% -$106K
MO icon
400
Altria Group
MO
$113B
– –
-8,700
Closed -$362K
14 15
16
17 18

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Candriam SCA's Q3 2020 Portfolio in Review

As of Q3 2020, Candriam SCA held 850 positions worth $10.6B, up 12% from $9.47B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA deployed $3.01B of net new capital in Q3 2020, opening 52 new positions and adding to 273 existing holdings. Its largest new stake was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 35% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $57.2M trimmed.

  • Candriam SCA's largest Q3 2020 buy was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.
  • Candriam SCA added most to Amgen in Q3 2020, an estimated $96.9M increase.
  • Candriam SCA's biggest Q3 2020 reduction was Apple, cutting an estimated $57.2M.
  • Candriam SCA fully exited G1 Therapeutics, Inc. Common Stock in Q3 2020, selling an estimated $21.1M.
  • Candriam SCA's ten largest holdings make up 22% of its $10.6B portfolio in Q3 2020.
  • Candriam SCA opened 52 new positions and closed 48 in Q3 2020.
  • Candriam SCA's portfolio value rose 12% quarter-over-quarter to $10.6B.

Based on Candriam SCA's 13F filing for Q3 2020, filed 19 Oct 2020.